stay updated with our newsletter

Omegas May Play a Role in Correcting Lipoprotein Patterns in Metabolic Syndrome

Anti-Inflammatory Function of HDL Cholesterol

Metabolic syndrome (MetSyn) is a multifaceted combination of cardiovascular disease risk factors and co-morbidities that include abdominal obesity, elevated triglycerides, mildly elevated blood pressure and fasting glucose, and low HDL-cholesterol.  Disagreements remain as to whether MetSyn risk factors act synergistically or independently. However the alterations in plasma triglycerides (TG) andRead

Statement from CRN’s Duffy MacKay, N.D. in the Value of Omega-3 Fatty Acids and Heart Health

In Jan. 2018, the Journal of the American Medical Association published a study, “Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.” The study received a number of negative media reports citing that Omega-3 fatty acids do little to reduce the risk of cardiovascular disease. In response toRead

Omega-3 fatty acids reduce breast cancer risk in post-menopausal women

The anti-inflammatory effect of omega-3 fatty acids may lower the breast cancer risk of obese, post-menopausal women. A study published in Cancer Prevention Research suggests that omega-3 fatty acids have a specific protective effect for obese, post menopausal women with dense breast tissue. Andrea Manni, professor and division chief of endocrinology,Read

Potential Inhibition of Cognitive Decline with B Vitamins & Omega-3s

This article, provided by our content partner Global Organization for EPA and DHA (GOED), discusses a previously unknown association related to the possible inhibition of progressive brain atrophy in mildly impaired elderly people with higher omega-3 long chain polyunsaturated fatty acid intake and B-vitamins. Previously published in Fats of Life,Read

Omega-3 May Improve Quality of Life for Pancreatic Cancer Patients

pancreatic cancer

The addition of intravenous omega-3 fatty acids to anti-tumor medications for pancreatic cancer may improve quality of life (QOL) and clinical response, according to researchers from the University Hospitals of Leicester, UK. The authors report that the first clinical trial of intravenous (IV) ω-3FAs as a therapeutic agent in anyRead

Omega-3 & ALA Fatty Acids May Reduce Lou Gehrig’s Disease Risk

Omega-3 fatty acids may play a role in cutting one’s risk of fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) by one third, a new study suggests from the Harvard School of Public Health in Boston. The research suggests that EFA’s could be part of prevention or integrative therapeutic treatment for ALS. By Kathryn C. Fitzgerald, M.Sc, JAMA Neurology, July 2014.

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.